Filed: 7/10/2025ACC: 0000950123-25-006247
📋 What this filing means
VIDA VENTURES ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $15.92M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$15.92M
Total AUM (reported)
6.32M
Total Shares
Allocation by class
COMMON STOCK$15.92M100.0%
Portfolio Concentration
Top 3$15.92M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 6.32M
Sole
Full voting authority
6.32M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
Kyverna Therapeutics, Inc.
SOLEShares4.52M
TypeSH
Market value$13.89M
87.24%
Sole
4.52M
Shared
0.00
None
0.00
Allogene Therapeutics, Inc.
SOLEShares1.80M
TypeSH
Market value$2.03M
12.76%
Sole
1.80M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Kyverna Therapeutics, Inc.SOLE | Common Stock | 4.52M | SH | $13.89M 87.24% | 4.52M | 0.00 | 0.00 |
Allogene Therapeutics, Inc.SOLE | Common Stock | 1.80M | SH | $2.03M 12.76% | 1.80M | 0.00 | 0.00 |